Conceptio
›
Archive
›
NCBI PubMed Central
NCBI PubMed Central
open access
Heterogeneity of thromboembolic risk across ALK inhibitors: a retrospective real-world study identifying crizotinib-specific signals and high-risk subpopulations.
Hu R et al.
· 2026
NCBI PubMed Central · Papers · License: Open Access · 2026
Open Source ↗
Direct PDF ↓
machine learning systems
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record
· ID 1054115
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.